Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. 4 Open-market sale Director sold 6,600,000 shares at an average $3.05 ($20,122,351)
  2. 4 Open-market sale Director sold 60,000 shares at $3.28 ($196,500)
  3. 3/A Insider 3/A
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy Director bought 200,000 shares at an average $0.34 ($67,256)
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy Director bought 20,000 shares at $0.38 ($7,680)
  12. 4 Open-market buy 10% owner bought 564,000 shares at an average $0.36 ($203,200)
  13. 4 Open-market buy 10% owner bought 436,000 shares at an average $0.35 ($150,552)
  14. 4 Open-market buy 10% owner bought 7,333,333 shares at an average $0.29 ($2,143,078)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market buy President and Chief Executive bought 166,667 shares at $0.30 ($50,000)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 28 · 550 filings